# Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

> **NCT05122806** · NA · RECRUITING · sponsor: **Groupe Francais De Pneumo-Cancerologie** · enrollment: 100 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- ALK Gene Rearrangement Positive

## Interventions

- **GENETIC:** RNAseq

## Key facts

- **NCT ID:** NCT05122806
- **Lead sponsor:** Groupe Francais De Pneumo-Cancerologie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-22
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05122806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05122806, "Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05122806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*